Regeneron Pharmaceuticals shares owned by Dillon & Associates
Quarter-by-quarter ownership of Regeneron Pharmaceuticals (REGN) shares owned by Dillon & Associates
from 13F filings
Historical chart of Dillon & Associates investment in Regeneron Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Regeneron Pharmaceuticals held by Dillon & Associates consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Regeneron Pharmaceuticals by Dillon & Associates
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $2.8M | 4.9k | 561.98 |
| 2025-06-30 | $7.0M | 13k | 525.03 |
| 2025-03-31 | $8.7M | 14k | 634.03 |
| 2024-12-31 | $9.9M | 14k | 711.99 |
| 2024-09-30 | $14M | 14k | 1051.02 |
| 2024-06-30 | $13M | 13k | 1051.00 |
| 2024-03-31 | $12M | 12k | 962.00 |
| 2023-12-31 | $10M | 12k | 878.00 |
| 2023-09-30 | $10M | 12k | 823.00 |
| 2023-06-30 | $8.5M | 12k | 719.03 |
| 2023-03-31 | $5.8M | 9.2k | 632.02 |
| 2022-12-31 | $7.6M | 11k | 721.05 |
| 2022-09-30 | $7.3M | 11k | 688.96 |
| 2022-06-30 | $6.0M | 10k | 590.96 |
| 2022-03-31 | $6.8M | 9.7k | 698.04 |
| 2021-12-31 | $5.8M | 9.2k | 632.02 |
| 2021-09-30 | $4.8M | 7.9k | 605.02 |
| 2021-06-30 | $3.6M | 6.4k | 559.01 |
| 2021-03-31 | $1.7M | 3.5k | 473.00 |